YML108W was identified in a high-copy suppressor screen designed to alleviate toxicity induced by a nuclear-localized, polyglutamine-expanded huntingtin fragment (Htt103Q-NLS) . The gene was isolated as part of a 5–10 kb genomic fragment (GF7) that suppressed Htt103Q-NLS toxicity in yeast. Key findings include:
Mechanism of Suppression: YML108W does not encode a polyglutamine-rich protein, unlike other suppressors (e.g., Pop2, Cbk1). Its suppressive effect is linked to changes in Htt103Q spatial organization, as evidenced by fluorescence microscopy showing reduced nuclear foci formation .
Protein Interactions: Co-immunoprecipitation assays indicate that YML108W may interact with Hsp70 and its co-chaperone Sti1, which mediate spatial quality control of amyloid-like proteins .
Expression Profiling: Microarray analysis of yeast cells under galactose-inducing conditions revealed YML108W expression levels of 0.670 (log2 fold change relative to controls) .
Genetic Deletion: Deletion of YML108W in the W303α strain (Δyml108w) did not confer overt growth defects under standard laboratory conditions, suggesting it is non-essential for viability .
YML108W’s role in HD models highlights its potential as a modifier of protein aggregation pathways. Huntington’s disease is characterized by toxic polyglutamine expansions in huntingtin (Htt), which form intracellular aggregates. YML108W’s ability to modulate these aggregates suggests it may influence:
Amyloid Seeding: YML108W expression reduces the formation of Htt103Q nuclear foci, which are linked to cytotoxicity .
Chaperone Networks: Its interaction with Hsp70/Sti1 implies a role in routing misfolded proteins into benign aggregates, mitigating cellular damage .
Despite its identification in HD models, YML108W remains poorly annotated. Key gaps include:
Molecular Function: No functional motifs or orthologs have been identified, limiting mechanistic insights .
Conservation: Homologs outside S. cerevisiae are absent in ortholog databases (e.g., OrthoMCL), raising questions about its evolutionary significance .
While YML108W is not directly linked to antibody development, its role in protein quality control pathways suggests utility in:
Therapeutic Targeting: Modulators of YML108W-like pathways could enhance chaperone-mediated clearance of toxic protein aggregates in neurodegenerative diseases .
Biomarker Discovery: Its expression changes in stress conditions (e.g., 0.670 log2 fold change under galactose induction) may inform diagnostic strategies.
All data cited are derived from peer-reviewed studies:
- Global analysis of SUMO chain function in yeast .
- Polyglutamine-rich suppressors of Huntington’s disease toxicity .
YML108W is a protein in Saccharomyces cerevisiae (Baker's yeast, strain ATCC 204508/S288c) that localizes to the nucleus and is involved in transcriptional processes. The antibody against YML108W serves as an important research tool for studying nuclear processes and transcriptional regulation in yeast models. This protein has been identified in studies examining RNA polymerase function, making it particularly valuable for understanding fundamental transcription mechanisms .
The significance of YML108W lies in its nuclear localization and potential role in co-transcriptional pre-mRNA processing, which provides insights into basic eukaryotic cellular mechanisms that are often conserved across species. Research with YML108W antibody enables scientists to track protein expression, localization, and interactions in experimental systems.
YML108W antibody has been validated for several research applications:
| Application | Validation Status | Common Dilutions | Notes |
|---|---|---|---|
| ELISA | Validated | 1:1000-1:5000 | Works well for quantitative detection |
| Western Blot | Validated | 1:500-1:2000 | Ensures identification of antigen |
| IHC | Not fully validated | - | Limited data available |
| IP | Not fully validated | - | Limited data available |
Both ELISA and Western Blot methodologies have been thoroughly tested for this antibody, allowing reliable identification and quantification of the target protein in yeast samples . When designing experiments, researchers should prioritize these validated applications while considering appropriate controls, especially when attempting non-validated applications.
Proper storage and handling are crucial for maintaining antibody activity. For YML108W antibody:
Store at -20°C or -80°C upon receipt
Avoid repeated freeze-thaw cycles that can degrade antibody activity
The antibody is supplied in liquid form with 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as preservative
Working aliquots should be prepared and stored separately to avoid freeze-thaw cycles of the stock solution
When handling the antibody, maintain cold chain practices and use sterile techniques to prevent contamination. For long-term studies, monitoring antibody activity through regular validation assays is recommended to ensure consistent experimental results.
Robust experimental design with appropriate controls is essential when working with YML108W antibody:
Essential Controls for YML108W Antibody Experiments:
Positive Control: Lysate from wild-type S. cerevisiae expressing YML108W
Negative Control:
Lysate from YML108W knockout strain
Secondary antibody only (no primary antibody)
Isotype Control: Non-specific rabbit IgG at the same concentration
Loading Control: Antibody against a housekeeping protein (e.g., actin) for normalization
When designing experiments, particularly for Western blot analyses, researchers should include both technical and biological replicates to account for variability. Additionally, when working with nuclear proteins like YML108W, subcellular fractionation controls are recommended to verify localization claims 5.
Optimizing Western blot protocols for YML108W antibody requires attention to several parameters:
Sample Preparation:
Blocking and Antibody Dilution:
Detection and Troubleshooting:
For weak signals, consider longer exposure times or signal enhancement systems
For high background, increase washing steps and dilute antibody further
If non-specific bands appear, optimize SDS-PAGE conditions and consider adding additional blocking steps
For complex experimental designs investigating transcriptional mechanisms:
Co-localization Studies:
Sequential Immunoprecipitation:
Use YML108W antibody for first-round IP followed by another antibody for suspected interaction partners
This approach helps confirm protein-protein interactions in transcriptional complexes
ChIP-Seq Integration:
YML108W antibody can be used in chromatin immunoprecipitation followed by sequencing
This reveals genomic binding sites and potential regulatory functions
Correlation with RNA-Seq data provides functional insights into transcriptional effects
These integrated approaches provide more comprehensive understanding than single-parameter experiments, though they require careful validation of each component method .
YML108W's nuclear localization suggests involvement in transcriptional processes. To study its role in transcriptional complexes:
Proximity Labeling Techniques:
BioID or APEX2 fusion constructs with YML108W can identify neighboring proteins
This reveals the protein's immediate interaction network in live cells
Co-immunoprecipitation coupled with Mass Spectrometry:
Using YML108W antibody for immunoprecipitation followed by MS analysis
This identifies stable interaction partners
R-loop Analysis using S9.6 Antibody:
Genetic Interaction Mapping:
Synthetic genetic array analysis with YML108W deletion/mutation
Identifies genes functionally related to YML108W through genetic interactions
These methodologies collectively provide a systems-level understanding of YML108W's function in transcriptional regulation and pre-mRNA processing.
Post-translational modifications (PTMs) often regulate nuclear protein functions. For YML108W:
Phospho-specific Antibody Development:
Generate antibodies against predicted phosphorylation sites
Use phosphatase treatments as controls to confirm specificity
Mass Spectrometry-based PTM Mapping:
Immunoprecipitate YML108W followed by tryptic digestion
MS/MS analysis identifies modified residues
Quantitative approaches (SILAC, TMT) can compare modification levels between conditions
Site-directed Mutagenesis Validation:
Create point mutations at putative modification sites
Functional assays determine the impact of preventing specific modifications
Kinase/Phosphatase Inhibitor Screens:
Treat cells with inhibitor panels to identify enzymes regulating YML108W
Monitor changes in modification state with the YML108W antibody
These approaches provide complementary information about YML108W regulation through post-translational modifications that may affect its function in transcriptional processes .
YML108W has paralogs in RNA polymerase I and III systems, suggesting evolutionary relationships between these transcriptional machineries:
Comparative Immunoprecipitation Studies:
Use specific antibodies against YML108W and its paralogs
Compare interacting partners to identify shared and unique components
This reveals functional conservation and specialization
Cross-system Functional Complementation:
Express YML108W in paralog-depleted cells
Assess rescue of paralog-dependent functions
This determines functional interchangeability
Evolutionary Analysis Approaches:
Phylogenetic comparisons across species
Identification of conserved domains and sequence motifs
This provides insight into the evolutionary history of these related proteins
Understanding these relationships helps elucidate the broader context of RNA polymerase evolution and functional specialization across different transcriptional systems .
When faced with experimental inconsistencies:
Antibody Validation Checks:
Confirm antibody lot-to-lot consistency with standard samples
Perform epitope blocking experiments to verify specificity
Consider using alternative antibody clones if available
Sample Preparation Optimization:
Standardize cell growth conditions and harvest protocols
Ensure complete nuclear extraction for nuclear proteins like YML108W
Monitor protein degradation with protease inhibitor cocktails
Technical Parameter Analysis:
Systematically vary incubation times, temperatures, and buffer compositions
Document all experimental conditions meticulously for troubleshooting
Implement statistical process control to identify sources of variation
Cross-Methodological Validation:
Careful documentation of all experimental conditions is essential for identifying sources of inconsistency and establishing reproducible protocols.
Exploratory Data Analysis:
Assess data distribution (normal vs. non-normal)
Identify outliers using box plots or Grubbs' test
Visualize data trends with appropriate plots
Appropriate Statistical Tests:
For normally distributed data: t-tests (two conditions) or ANOVA (multiple conditions)
For non-normally distributed data: non-parametric alternatives (Mann-Whitney, Kruskal-Wallis)
For time-course studies: repeated measures ANOVA or mixed-effects models
Multiple Testing Correction:
Apply Bonferroni or Benjamini-Hochberg procedures
Report both uncorrected and corrected p-values
Balance Type I and Type II error risks
Power Analysis and Sample Size Calculation:
Determine required sample size for desired statistical power
Consider biological variation when designing experiments
Report power calculations in methodology sections5
When integrating data from multiple techniques:
Standardized Reporting:
Report all methodological details including antibody dilutions, incubation times, and detection methods
Include relevant controls for each technique
Normalize data appropriately within each method
Correlation Analysis:
Calculate correlation coefficients between techniques
Generate Bland-Altman plots to assess systematic differences
Identify technique-specific biases
Meta-Analytical Approaches:
Combine results across techniques using formal meta-analysis
Weight evidence based on methodological quality and rigor
Produce consensus estimations of YML108W properties
Technology-Specific Limitations Documentation:
This systematic approach to cross-technique comparisons produces more reliable and comprehensive understanding of YML108W's properties and functions.
Several cutting-edge approaches can advance YML108W research:
CRISPR-Cas9 Genome Editing:
Generate precise modifications of YML108W
Create tagged versions for live-cell imaging
Establish conditional knockout systems for temporal studies
Single-Cell Approaches:
Single-cell RNA-seq to examine cell-to-cell variation in YML108W-dependent processes
Single-cell proteomics to correlate YML108W levels with other proteins
This reveals heterogeneity masked in population averages
Advanced Imaging Techniques:
STORM/PALM super-resolution microscopy for precise localization
FRET/FLIM for studying protein-protein interactions in living cells
Light-sheet microscopy for long-term dynamic studies
Synthetic Biology Approaches:
These emerging technologies offer new ways to interrogate YML108W function with unprecedented precision and context.
Bispecific antibody technology offers innovative approaches for YML108W studies:
Simultaneous Detection Applications:
Design bispecific antibodies targeting YML108W and interaction partners
This enables co-detection without secondary antibody complications
Particularly valuable for multi-color microscopy and flow cytometry
Proximity-Based Assays:
Create bispecific antibodies linking YML108W to reporter systems
This enables functional readouts based on localization or interactions
Can be adapted for high-throughput screening applications
Design Considerations:
The application of bispecific antibody technology to YML108W research represents an emerging frontier that combines antibody engineering advances with specific research needs in transcriptional biology.